(CRBN) MSCI ACWI Low Carbon Target - Overview
Etf: Stocks, Global, Low-Carbon, Equity, Index
Dividends
| Dividend Yield | 2.32% |
| Yield on Cost 5y | 3.60% |
| Yield CAGR 5y | 16.75% |
| Payout Consistency | 97.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.3% |
| Relative Tail Risk | 4.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 7.02 |
| Character TTM | |
|---|---|
| Beta | 0.859 |
| Beta Downside | 0.834 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.60% |
| CAGR/Max DD | 1.19 |
Description: CRBN MSCI ACWI Low Carbon Target January 20, 2026
The iShares MSCI ACWI Low Carbon Target ETF (CRBN) aims to track an index that screens global large-cap equities for both current carbon emissions and the carbon intensity of fossil-fuel reserves, allocating at least 80 % of its assets to securities that are identical or “substantially identical” to the index constituents.
Key metrics (as of 2024): the fund’s expense ratio is 0.20 %, its carbon-intensity score (weighted average tCO₂e per million USD revenue) is roughly 30 % lower than the broader MSCI ACWI, and it holds about USD 5 billion in assets under management, with top sector exposures to Information Technology (≈ 22 %) and Health Care (≈ 15 %).
Drivers of performance include the ongoing regulatory push for net-zero targets in the EU and U.S., which can reprice high-carbon sectors, and the gradual shift of capital toward companies with disclosed transition plans-factors that historically boost the relative outperformance of low-carbon indices during periods of heightened climate policy activity.
For a deeper, data-rich analysis of CRBN’s risk-adjusted returns and carbon-reduction impact, you might explore the ValueRay platform’s interactive dashboard.
What is the price of CRBN shares?
Over the past week, the price has changed by -0.18%, over one month by +1.07%, over three months by +4.00% and over the past year by +20.65%.
Is CRBN a buy, sell or hold?
What are the forecasts/targets for the CRBN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 280.3 | 18.2% |
CRBN Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.03b USD (1.03b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.03b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.03b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.08% (E(1.03b)/V(1.03b) * Re(9.08%) + (debt-free company))
Discount Rate = 9.08% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)